TAK — Takeda Pharmaceutical Co News Story

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapNeutral

Market Cap
$41.22bn
Enterprise Value
$69.15bn
Revenue
¥4tn

All News

REG-Millennium Partners, L.P. Form 8.3 - Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical CoAnnouncement

27/12/2018 15:15

Form 8.3 - Takeda Pharmaceutical Company Limited

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:		Millennium International Management LP
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree		Takeda Pharmaceutical Company Limited
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure		26^th December 2018
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”		Yes, Shire plc

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:	Ordinary (JP3463000004) - interest held via holding of ADS and ADS Option (US8740602052)
	Interests		Short positions
	Number	%	Number	%
(1) Relevant securities owned and/or controlled:	313,000	0.040%	11,467,578	1.460%
(2) Cash-settled derivatives:	1,212,494	0.155%	809,373	0.103%
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:	250,000	0.032%	0	0.000%
TOTAL:	1,775,494	0.226%	12,276,957	1.565%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security	Purchase/sale	Number of securities	Price per unit (USD)
US8740602052	Sale	4,600	17.07
US8740602052	Sale	3,783	17.08
US8740602052	Sale	7,817	17.09
US8740602052	Sale	1,400	17.10
US8740602052	Sale	1,500	17.11
US8740602052	Sale	500	17.12
US8740602052	Sale	1,200	17.13
US8740602052	Sale	2,800	17.14
US8740602052	Sale	1,600	17.15
US8740602052	Sale	1,800	17.16
US8740602052	Sale	500	17.20
US8740602052	Purchase	2,100	17.08
US8740602052	Sale	501	17.00
US8740602052	Sale	100	17.01
US8740602052	Sale	100	17.05
US8740602052	Sale	2,840	17.06
US8740602052	Sale	100	17.09
US8740602052	Sale	1,000	17.10
US8740602052	Sale	2,800	17.11
US8740602052	Sale	300	17.12
US8740602052	Sale	700	17.13
US8740602052	Sale	600	17.15
US8740602052	Sale	1,241	17.16
US8740602052	Sale	2,000	17.17
US8740602052	Sale	100	17.19
US8740602052	Sale	100	17.20
US8740602052	Sale	100	17.21
US8740602052	Sale	3	17.31

Class of relevant security	Purchase/sale	Number of securities	Price per unit (JPY)
JP3463000004	Sale	100	3663.00
JP3463000004	Sale	100	3664.00
JP3463000004	Sale	100	3665.00
JP3463000004	Sale	200	3666.00
JP3463000004	Sale	200	3667.00
JP3463000004	Sale	300	3668.00
JP3463000004	Sale	200	3669.00
JP3463000004	Sale	200	3674.00
JP3463000004	Sale	200	3676.00
JP3463000004	Sale	100	3679.00
JP3463000004	Sale	200	3680.00
JP3463000004	Sale	300	3681.00
JP3463000004	Sale	100	3683.00
JP3463000004	Sale	100	3684.00
JP3463000004	Sale	100	3686.00
JP3463000004	Sale	100	3687.00
JP3463000004	Sale	200	3688.00
JP3463000004	Sale	400	3689.00
JP3463000004	Sale	400	3690.00
JP3463000004	Sale	300	3691.00
JP3463000004	Sale	100	3693.00
JP3463000004	Sale	300	3694.00
JP3463000004	Sale	200	3695.00
JP3463000004	Sale	300	3696.00
JP3463000004	Sale	200	3697.00
JP3463000004	Sale	100	3698.00
JP3463000004	Sale	300	3699.00
JP3463000004	Sale	100	3700.00
JP3463000004	Sale	300	3701.00
JP3463000004	Sale	300	3702.00
JP3463000004	Sale	300	3703.00
JP3463000004	Sale	100	3704.00
JP3463000004	Sale	300	3706.00
JP3463000004	Sale	100	3710.00
JP3463000004	Sale	200	3713.00
JP3463000004	Sale	200	3716.00
JP3463000004	Sale	1,900	3718.00
JP3463000004	Sale	100	3719.00
JP3463000004	Sale	200	3720.00
JP3463000004	Sale	200	3721.00
JP3463000004	Sale	100	3723.00
JP3463000004	Sale	100	3725.00
JP3463000004	Sale	200	3732.00
JP3463000004	Sale	100	3733.00
JP3463000004	Purchase	100	3660.50
JP3463000004	Purchase	100	3661.50
JP3463000004	Purchase	200	3663.00
JP3463000004	Purchase	800	3663.50
JP3463000004	Purchase	200	3664.00
JP3463000004	Purchase	400	3665.00
JP3463000004	Purchase	800	3665.50
JP3463000004	Purchase	100	3666.00
JP3463000004	Purchase	800	3666.50
JP3463000004	Purchase	300	3667.00
JP3463000004	Purchase	800	3667.50
JP3463000004	Purchase	1,200	3668.00
JP3463000004	Purchase	2,300	3668.50
JP3463000004	Purchase	400	3669.00
JP3463000004	Purchase	1,600	3669.50
JP3463000004	Purchase	300	3670.00
JP3463000004	Purchase	200	3670.50
JP3463000004	Purchase	300	3671.50
JP3463000004	Purchase	100	3672.00
JP3463000004	Purchase	500	3672.50
JP3463000004	Purchase	300	3673.50
JP3463000004	Purchase	100	3674.00
JP3463000004	Purchase	600	3674.50
JP3463000004	Purchase	700	3675.50
JP3463000004	Purchase	800	3676.00
JP3463000004	Purchase	300	3676.50
JP3463000004	Purchase	200	3677.00
JP3463000004	Purchase	600	3677.50
JP3463000004	Purchase	500	3678.00
JP3463000004	Purchase	600	3678.50
JP3463000004	Purchase	600	3679.00
JP3463000004	Purchase	400	3679.50
JP3463000004	Purchase	900	3680.50
JP3463000004	Purchase	400	3681.00
JP3463000004	Purchase	400	3681.50
JP3463000004	Purchase	400	3682.00
JP3463000004	Purchase	100	3682.50
JP3463000004	Purchase	100	3683.00
JP3463000004	Purchase	400	3683.50
JP3463000004	Purchase	400	3684.00
JP3463000004	Purchase	500	3684.50
JP3463000004	Purchase	600	3685.00
JP3463000004	Purchase	200	3685.50
JP3463000004	Purchase	200	3686.00
JP3463000004	Purchase	600	3686.50
JP3463000004	Purchase	300	3687.00
JP3463000004	Purchase	400	3687.50
JP3463000004	Purchase	600	3688.50
JP3463000004	Purchase	500	3689.00
JP3463000004	Purchase	900	3689.50
JP3463000004	Purchase	400	3690.00
JP3463000004	Purchase	600	3690.17
JP3463000004	Purchase	1,000	3690.50
JP3463000004	Purchase	800	3691.00
JP3463000004	Purchase	900	3691.50
JP3463000004	Purchase	400	3692.00
JP3463000004	Purchase	300	3692.50
JP3463000004	Purchase	100	3693.00
JP3463000004	Purchase	500	3693.50
JP3463000004	Purchase	500	3694.00
JP3463000004	Purchase	300	3695.00
JP3463000004	Purchase	500	3695.50
JP3463000004	Purchase	100	3696.00
JP3463000004	Purchase	100	3697.00
JP3463000004	Purchase	500	3698.00
JP3463000004	Purchase	700	3698.14
JP3463000004	Purchase	400	3698.50
JP3463000004	Purchase	1,000	3699.00
JP3463000004	Purchase	2,600	3700.00
JP3463000004	Purchase	3,100	3700.61
JP3463000004	Purchase	2,800	3701.00
JP3463000004	Purchase	500	3701.50
JP3463000004	Purchase	700	3702.00
JP3463000004	Purchase	300	3702.50
JP3463000004	Purchase	100	3702.90
JP3463000004	Purchase	2,000	3703.00
JP3463000004	Purchase	1,400	3704.00
JP3463000004	Purchase	1,500	3705.00
JP3463000004	Purchase	900	3706.00
JP3463000004	Purchase	100	3706.50
JP3463000004	Purchase	700	3707.00
JP3463000004	Purchase	700	3707.50
JP3463000004	Purchase	500	3708.00
JP3463000004	Purchase	100	3709.00
JP3463000004	Purchase	900	3710.00
JP3463000004	Purchase	400	3711.00
JP3463000004	Purchase	100	3711.50
JP3463000004	Purchase	300	3712.00
JP3463000004	Purchase	900	3715.00
JP3463000004	Purchase	400	3716.00
JP3463000004	Purchase	100	3717.00
JP3463000004	Purchase	7,400	3718.00
JP3463000004	Sale	400	3661.00
JP3463000004	Sale	500	3662.00
JP3463000004	Sale	700	3663.00
JP3463000004	Sale	300	3664.00
JP3463000004	Sale	400	3666.00
JP3463000004	Sale	1,900	3667.00
JP3463000004	Sale	2,000	3668.00
JP3463000004	Sale	700	3669.00
JP3463000004	Sale	1,400	3670.00
JP3463000004	Sale	100	3671.00
JP3463000004	Sale	600	3673.00
JP3463000004	Sale	100	3673.50
JP3463000004	Sale	500	3674.00
JP3463000004	Sale	1,400	3675.00
JP3463000004	Sale	1,900	3676.00
JP3463000004	Sale	1,600	3677.00
JP3463000004	Sale	100	3677.50
JP3463000004	Sale	2,700	3678.00
JP3463000004	Sale	100	3678.10
JP3463000004	Sale	3,200	3679.00
JP3463000004	Sale	2,900	3680.00
JP3463000004	Sale	1,800	3681.00
JP3463000004	Sale	1,200	3682.00
JP3463000004	Sale	800	3682.75
JP3463000004	Sale	1,100	3683.00
JP3463000004	Sale	2,100	3684.00
JP3463000004	Sale	800	3686.00
JP3463000004	Sale	2,400	3687.00
JP3463000004	Sale	1,500	3688.00
JP3463000004	Sale	1,400	3689.00
JP3463000004	Sale	2,700	3690.00
JP3463000004	Sale	2,400	3691.00
JP3463000004	Sale	800	3692.00
JP3463000004	Sale	1,200	3693.00
JP3463000004	Sale	600	3694.00
JP3463000004	Sale	800	3695.00
JP3463000004	Sale	1,100	3696.00
JP3463000004	Sale	800	3697.00
JP3463000004	Sale	800	3699.00
JP3463000004	Sale	2,400	3700.00
JP3463000004	Sale	600	3701.00
JP3463000004	Sale	600	3702.00
JP3463000004	Sale	600	3703.00
JP3463000004	Sale	600	3709.00
JP3463000004	Sale	2,400	3710.00
JP3463000004	Sale	2,500	3711.00
JP3463000004	Sale	400	3712.00
JP3463000004	Sale	300	3713.00
JP3463000004	Sale	900	3714.00
JP3463000004	Sale	1,700	3715.00
JP3463000004	Sale	1,300	3716.00
JP3463000004	Sale	13,000	3718.00
JP3463000004	Sale	600	3719.00
JP3463000004	Sale	900	3720.00
JP3463000004	Sale	600	3722.00
JP3463000004	Sale	600	3723.00
JP3463000004	Sale	600	3724.00
JP3463000004	Sale	700	3726.00

(b) Cash-settled derivative transactions

Class of relevant security	Product description e.g. CFD	Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position	Number of reference securities	Price per unit
JP3463000004	CFD	Increasing a short position	400	3,706.00
JP3463000004	CFD	Reducing a long position	4,000	3,703.83
JP3463000004	CFD	Reducing a long position	61,800	3,692.21

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

NONE

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

YES

Date of disclosure:		27^th December 2018
Contact name:		Myriam Soper
Telephone number:		+44 203 650 8261

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the “Code”)

1. KEY INFORMATION

Full name of person making disclosure:		Millennium International Management LP
Name of offeror/offeree in relation to whose relevant securities the disclosure relates:		Takeda Pharmaceutical Company Limited

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of relevant security

Product description e.g. call option

Written or purchased

Number of securities to which option or derivative relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

US8740602052

Call Option

Purchased

250,000

4,200 JPY

American

20190308

3. AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk

View source version on businesswire.com: https://www.businesswire.com/news/home/20181227005250/en/

Millennium Partners, L.P.

TAK — Takeda Pharmaceutical Co News Story

REG-Millennium Partners, L.P. Form 8.3 - Takeda Pharmaceutical Company Limited

Recent news on Takeda Pharmaceutical Co

REG - Malin Corp PLC - Malin Announces 2021 Full Year Results

REG - Takeda Pharma.Co.Ltd Shire plc - Confirmation of post-offer intention statements

REG - Morgan Stanley&CoLLC Takeda Pharma.Co.Ltd - Form 8.5 (EPT/RI) - Replacement of Takeda

REG - Takeda Pharma.Co.Ltd Shire plc - Statement re Applicable Exchange Rate

REG - Morgan Stanley Takeda Pharma.Co.Ltd - Form 8.5 (EPT/NON-RI) - Replacement of Takeda